Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Notes Payables (2023 - 2025)

HUTCHMED (China) (HCM) has disclosed Notes Payables for 3 consecutive years, with $25.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Notes Payables rose 6.84% to $25.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $25.0 million, a 6.84% increase, with the full-year FY2025 number at $25.0 million, up 6.84% from a year prior.
  • Notes Payables was $25.0 million for Q4 2025 at HUTCHMED (China), up from $23.4 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $31.2 million in Q4 2023 to a low of $23.4 million in Q4 2024.
  • A 3-year average of $26.5 million and a median of $25.0 million in 2025 define the central range for Notes Payables.
  • Peak YoY movement for Notes Payables: decreased 24.98% in 2024, then rose 6.84% in 2025.
  • HUTCHMED (China)'s Notes Payables stood at $31.2 million in 2023, then fell by 24.98% to $23.4 million in 2024, then grew by 6.84% to $25.0 million in 2025.
  • Per Business Quant, the three most recent readings for HCM's Notes Payables are $25.0 million (Q4 2025), $23.4 million (Q4 2024), and $31.2 million (Q4 2023).